Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer-Reference-Cited by-同舟云学术

Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer

Published:2016-06-03 Issue:11 Volume:117 Page:2454-2463
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Chamberlin Mary D.¹²³,Bernhardt Erica B.¹,Miller Todd W.³⁴

Affiliation:

1. Department of Medicine, Norris Cotton Cancer Center; Geisel School of Medicine at Dartmouth; Lebanon New Hampshire

2. Department of Hematology-Oncology, One Medical Center Dr.; Dartmouth-Hitchcock Medical Center; Lebanon New Hampshire

3. Comprehensive Breast Program, Norris Cotton Cancer Center; Geisel School of Medicine at Dartmouth; Lebanon New Hampshire

4. Department of Pharmacology and Toxicology, Norris Cotton Cancer Center; Geisel School of Medicine at Dartmouth; Lebanon New Hampshire

Funder

American Cancer Society

Mary Kay Foundation

Susan G. Komen for the Cure

NIH (Dartmouth College Norris Cotton Cancer Center)

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference109 articles.

1. Abramson VG Lehmann B Mayer IA Arteaga CL Pietenpol JA 2014

2. Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy;Acevedo-Gadea;Breast Cancer Res Treat,2015

3. Perturbations of the AKT signaling pathway in human cancer;Altomare;Oncogene,2005

4. Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer;Amir;J Clin Oncol,2012

5. A multicenter, open-label phase II trial of dovitinib, an FGFR1 inhibitor, in FGFR1 amplified and non-amplified metastatic breast cancer;Andre;ASCO Annual Meeting Proceedings,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics;Pathology - Research and Practice;2024-08

2. Molecular Progression of Breast Cancer and Personalized Medicine in Terms of Clinical Trials;Breast Cancer: From Bench to Personalized Medicine;2022

3. Involvement of Par-4 in Breast Cancer;Tumor Suppressor Par-4;2021

4. Next generation sequencing-based gene panel tests for the management of solid tumors;Cancer Science;2018-11-27

5. Actionable Gene Alterations in an Asian Population With Triple-Negative Breast Cancer;JCO Precision Oncology;2018-11